Tissue management in precision medicine: What the pathologist needs to know in the molecular era

Precision medicine is “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” Among many medical specialists involved in precision medicine, the pathologists play an important and key role in the...

Full description

Bibliographic Details
Main Authors: Ricella Souza da Silva, Regina Pinto, Luis Cirnes, Fernando Schmitt
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.983102/full
_version_ 1797991853780369408
author Ricella Souza da Silva
Regina Pinto
Luis Cirnes
Fernando Schmitt
Fernando Schmitt
Fernando Schmitt
author_facet Ricella Souza da Silva
Regina Pinto
Luis Cirnes
Fernando Schmitt
Fernando Schmitt
Fernando Schmitt
author_sort Ricella Souza da Silva
collection DOAJ
description Precision medicine is “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” Among many medical specialists involved in precision medicine, the pathologists play an important and key role in the implementation and development of molecular tests that are in the center of decision of many therapeutic choices. Besides many laboratory procedures directly involved in the molecular tests, is fundamental to guarantee that tissues and cells collected for analysis be managed correctly before the DNA/RNA extraction. In this paper we explore the pivotal and interconnected points that can influence molecular studies, such as pre-analytical issues (fixation and decalcification); diagnosis and material selection, including the calculation of nuclei neoplastic fraction. The standardization of sample processing and morphological control ensures the accuracy of the diagnosis. Tissue or cytological samples constitutes the main foundation for the determination of biomarkers and development of druggable targets. Pathology and precision oncology still have a long way to go in terms of research and clinical practice: improving the accuracy and dissemination of molecular tests, learning in molecular tumor boards for advanced disease, and knowledge about early disease. Precision medicine needs pathology to be precise.
first_indexed 2024-04-11T08:58:45Z
format Article
id doaj.art-bf606db208d049c7bbabfc8602f03c61
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-11T08:58:45Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-bf606db208d049c7bbabfc8602f03c612022-12-22T04:33:05ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-10-01910.3389/fmolb.2022.983102983102Tissue management in precision medicine: What the pathologist needs to know in the molecular eraRicella Souza da Silva0Regina Pinto1Luis Cirnes2Fernando Schmitt3Fernando Schmitt4Fernando Schmitt5IPATIMUP Diagnostics, IPATIMUP—Institute of Molecular Pathology and Immunology of Porto University, University of Porto, Porto, PortugalIPATIMUP Diagnostics, IPATIMUP—Institute of Molecular Pathology and Immunology of Porto University, University of Porto, Porto, PortugalIPATIMUP Diagnostics, IPATIMUP—Institute of Molecular Pathology and Immunology of Porto University, University of Porto, Porto, PortugalIPATIMUP Diagnostics, IPATIMUP—Institute of Molecular Pathology and Immunology of Porto University, University of Porto, Porto, PortugalDepartment of Pathology, Faculty of Medicine of the University of Porto, University of Porto, Porto, PortugalCINTESIS@RISE (Health Research Network), Porto, PortugalPrecision medicine is “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” Among many medical specialists involved in precision medicine, the pathologists play an important and key role in the implementation and development of molecular tests that are in the center of decision of many therapeutic choices. Besides many laboratory procedures directly involved in the molecular tests, is fundamental to guarantee that tissues and cells collected for analysis be managed correctly before the DNA/RNA extraction. In this paper we explore the pivotal and interconnected points that can influence molecular studies, such as pre-analytical issues (fixation and decalcification); diagnosis and material selection, including the calculation of nuclei neoplastic fraction. The standardization of sample processing and morphological control ensures the accuracy of the diagnosis. Tissue or cytological samples constitutes the main foundation for the determination of biomarkers and development of druggable targets. Pathology and precision oncology still have a long way to go in terms of research and clinical practice: improving the accuracy and dissemination of molecular tests, learning in molecular tumor boards for advanced disease, and knowledge about early disease. Precision medicine needs pathology to be precise.https://www.frontiersin.org/articles/10.3389/fmolb.2022.983102/fullmolecular pathologymorphological controloncology precisionpersonalized medicinetissue managementsolid tumors
spellingShingle Ricella Souza da Silva
Regina Pinto
Luis Cirnes
Fernando Schmitt
Fernando Schmitt
Fernando Schmitt
Tissue management in precision medicine: What the pathologist needs to know in the molecular era
Frontiers in Molecular Biosciences
molecular pathology
morphological control
oncology precision
personalized medicine
tissue management
solid tumors
title Tissue management in precision medicine: What the pathologist needs to know in the molecular era
title_full Tissue management in precision medicine: What the pathologist needs to know in the molecular era
title_fullStr Tissue management in precision medicine: What the pathologist needs to know in the molecular era
title_full_unstemmed Tissue management in precision medicine: What the pathologist needs to know in the molecular era
title_short Tissue management in precision medicine: What the pathologist needs to know in the molecular era
title_sort tissue management in precision medicine what the pathologist needs to know in the molecular era
topic molecular pathology
morphological control
oncology precision
personalized medicine
tissue management
solid tumors
url https://www.frontiersin.org/articles/10.3389/fmolb.2022.983102/full
work_keys_str_mv AT ricellasouzadasilva tissuemanagementinprecisionmedicinewhatthepathologistneedstoknowinthemolecularera
AT reginapinto tissuemanagementinprecisionmedicinewhatthepathologistneedstoknowinthemolecularera
AT luiscirnes tissuemanagementinprecisionmedicinewhatthepathologistneedstoknowinthemolecularera
AT fernandoschmitt tissuemanagementinprecisionmedicinewhatthepathologistneedstoknowinthemolecularera
AT fernandoschmitt tissuemanagementinprecisionmedicinewhatthepathologistneedstoknowinthemolecularera
AT fernandoschmitt tissuemanagementinprecisionmedicinewhatthepathologistneedstoknowinthemolecularera